Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery

New England Journal of Medicine

Volumn 303, Issue 23, 1980, Pages 1323-1329

  Walker, Michael D ^a   Green, Sylvan B ^a   Byar, David P ^a   Alexander, Eben ^a   Batzdorf, Ulrich ^a   Brooks, William H ^a   Hunt, William E ^a   Maccarty, Collin S ^a   Mahaley, M Stephen ^a   Mealey, John ^a   Owens, Guy ^a   Ransohoff, Joseph ^a   Robertson, James T ^a   Shapiro, William R ^a   Smith, Kenneth R ^a   Wilson, Charles B ^a   Strike, Thomas A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CARMUSTINE; DEXAMETHASONE; METHYLPREDNISOLONE; SEMUSTINE;

BRAIN; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; NERVOUS SYSTEM; NEUROSURGERY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SURGERY; THERAPY;

EID: 0019142613     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198012043032303     Document Type: Article

References (13)

1. Walker M.D. Brain and peripheral nervous system tumors. In: Holland JF, Frei E III, eds. Cancer medicine. Philadelphia: Lea & Febiger, 1973: 1385-407.
2. Walker M.D., Alexander E. Jr., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg. 1978; 49:333-343.
3. Schabel F.M. Jr. Nitrosoureas: a review of experimental antitumor activity. Cancer Treat Rep. 1976; 60:665-698.
4. Young R.C., Walker M.D., Canellos G.P., Schein P.S., Chabner B.A., DeVita V.T. Initial clinical trials with methyl-CCNU l-(2-Chloroethyl)-3-(4-Methyl Cyclohexyl)-1-Nitrosourea (MeCCNU). Cancer 1973; 31: 1164-9.
5. Gehan E.A., Walker M.D. Prognostic factors for patients with brain tumors. In: Modern concepts in brain tumor therapy: laboratory and clinical investigations. Washington, D.C.: Government Printing Office, 1977: 189-95. (National Cancer Institute monograph no. 46) (DHEW publication no. [NIH]77-1236).
6. Burger P.C. Vogel FS. Surgical pathology of the nervous system and its coverings. New York: John Wiley, 1976: 189-373.
7. Karnofsky D.A., Abelmann W.H., Craver L.F., Burchenal J.H. The use of the nitrogen mustards in the palliative treatment of carcinoma: with particular reference to bronchogenic carcinoma. Cancer, 1948; 1:634-656.
8. Cutler S.J., Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958; 8:699-712.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50:163-170.
10. Gehan E.A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika. 1965; 52:203-223.
11. Tarone R.E., Ware J. On distribution-free tests for equality of survival distributions. Biometrika. 1977; 64:156-160.
12. Cox D.R. Regression models and life tables. J R Statist Soc [B]. 1972; 34:187-202.
13. Byar D.P., Green S.B., Dor P., et al. A prognostic index for thyroid carcinoma: a study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979; 15:1033-1041.